Position in NTRA
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$26,058
+$3,060 QoQ
Shares Held
96
-16.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#723
of 844 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SJS Investment Consulting Inc. holds $678,377 across 30 Diagnostics & Research names. NTRA ranks #10 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
626 | $110,068 | |
| 2 | A |
Agilent Technologies, Inc.
|
782 | $103,873 | |
| 3 | RVTY |
Revvity, Inc.
|
703 | $78,215 | |
| 4 | DGX |
Quest Diagnostics Inc
|
297 | $62,949 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
118 | $59,159 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
71 | $37,376 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
69 | $36,540 | |
| 8 | DHR |
Danaher Corp /De/
|
154 | $29,333 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,058 | 96 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $22,998 | 115 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $32,988 | 144 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $482 | 3 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $506 | 3 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $707 | 5 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $633 | 4 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $380 | 3 | Shares | Defined | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||